Pharming (PHAR) Change in Cash (2019 - 2026)

Pharming (PHAR) has 7 years of Change in Cash data on file, last reported at $11.7 million in Q4 2025.

• Quarterly Change in Cash rose 354.94% year-over-year to $11.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$128.0 million (up 32.34% YoY) and the FY2025 annual result came in at $82.5 million, up 1896.77% from the prior year.
• Change in Cash improved to $11.7 million in Q4 2025, from -$4.6 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $12.7 million in Q3 2024 to a low of -$147.7 million in Q4 2023.
• A 5-year average of -$27.7 million and a median of -$3.6 million in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2021 — Change in Cash surged 1475.81% — and 2023, when it tumbled 5464.18%.
• Tracing PHAR's Change in Cash over 5 years: stood at $2.1 million in 2021, then plunged by 225.47% to -$2.7 million in 2022, then plunged by 5464.18% to -$147.7 million in 2023, then soared by 96.89% to -$4.6 million in 2024, then soared by 354.94% to $11.7 million in 2025.
• The last three Change in Cash figures came in at $11.7 million (Q4 2025), -$4.6 million (Q4 2024), and $12.7 million (Q3 2024), per Business Quant data.